MedTrace Logo

VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical

NCT04911738 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-21

No results posted yet for this study

Summary

VIRGIL is a monocentric interventional study aiming to investigate the effect of immersion in a virtual tilted room on modulation of the verticality representation (postural vertical \[PV\] and visual vertical \[VV\]), which in turn might affect body orientation (head and trunk). To this end, the investigators will conduct a within-person randomized trial including post-stroke patients and healthy participants.

Conditions

  • Stroke
  • Brain Diseases
  • Cerebrovascular Disorders
  • Postural; Defect
  • Cognition Disorder

Interventions

OTHER

Virtual Reality , immersion in a virtual titlted room

The immersion in virtual reality will be based on the HTC VIVE® device and the software developed by the Virtualis Society.

Sponsors & Collaborators

  • Fondation Paul Bennetot

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Dominic Pérennou · University Hospital, Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2026-03-31
Completion
2026-05-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04911738 on ClinicalTrials.gov